Indigotindisulfonate

CHEMBL1091250 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
422.4 g/mol
LogP
0.2
Phase
4

This blue dye derived from indigo is used medically as a diagnostic tool, particularly to identify urinary tract structures and detect leaks during surgical procedures. When injected intravenously, it is rapidly excreted by the kidneys, staining urine blue to help surgeons visualize ureteral openings.

Molekularmasse

422,4000 g/mol

LogP

0,20

TPSA

191,00 Ų

Lipinski-Regel der Fünf

Bestanden

Wirkmechanismus

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1/C(=C2\Nc3ccc(S(=O)(=O)O)cc3C2=O)Nc2ccc(S(=O)(=O)O)cc21

InChI

InChI=1S/C16H10N2O8S2/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14/h1-6,17-18H,(H,21,22,23)(H,24,25,26)/b14-13+

Molecular Formula

C16H10N2O8S2

HBD / HBA

4 / 9

Rotierbare Bindungen

3

Schwere Atome

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This blue dye derived from indigo is used medically as a diagnostic tool, particularly to identify urinary tract structures and detect leaks during surgical procedures. When injected intravenously, it is rapidly excreted by the kidneys, staining urine blue to help surgeons visualize ureteral openings.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Indigotindisulfonate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1091250. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3705. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.